184 related articles for article (PubMed ID: 36213825)
41. Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis.
Pei S; Chen L; Yang Y; Zhu X
Head Neck; 2020 Sep; 42(9):2460-2472. PubMed ID: 32459022
[TBL] [Abstract][Full Text] [Related]
42. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
[TBL] [Abstract][Full Text] [Related]
43. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
44. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
Yang Y; Gao Y; Liu XS; Huang ZM; Zhang Y; Zhang YH; Liu ZY; Chen YX; Pei ZJ
Exp Ther Med; 2024 Aug; 28(2):305. PubMed ID: 38873045
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of nicotinamide adenine dinucleotide (NAD
Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
[TBL] [Abstract][Full Text] [Related]
46. Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
Liao Y; Wang Y; Cheng M; Huang C; Fan X
Front Genet; 2020; 11():311. PubMed ID: 32391047
[No Abstract] [Full Text] [Related]
47. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
48. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
[TBL] [Abstract][Full Text] [Related]
49. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Xu H; Zou R; Liu J; Zhu L
J Oncol; 2021; 2021():6653247. PubMed ID: 33747079
[TBL] [Abstract][Full Text] [Related]
50. Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma.
Zhang Y; Zhang R; Zeng L; Wang H; Peng R; Zhang M; Zhang H; Yang Z; Gao L; Wang M; Liu J
Stem Cells Int; 2022; 2022():1534593. PubMed ID: 35859724
[TBL] [Abstract][Full Text] [Related]
51. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S
Front Oncol; 2021; 11():651622. PubMed ID: 34367952
[TBL] [Abstract][Full Text] [Related]
52. Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival.
Li H; Wu Z; Zhang Y; Lu X; Miao L
Front Oncol; 2023; 13():1201297. PubMed ID: 37377916
[TBL] [Abstract][Full Text] [Related]
53. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract][Full Text] [Related]
54. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
55. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
56. Investigating the Lung Adenocarcinoma Stem Cell Biomarker Expressions Using Machine Learning Approaches.
Bhuvaneswari MS; Priyadharsini S; Balaganesh N; Theenathayalan R; Hailu TA
Biomed Res Int; 2022; 2022():3518190. PubMed ID: 36193299
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
[TBL] [Abstract][Full Text] [Related]
58. High expression of centromere protein N as novel biomarkers for gastric adenocarcinoma.
Wang X; Zhang K; Fu C; Wu F; Zhang J; Han B; Pan H; Luan L
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1798. PubMed ID: 36916294
[TBL] [Abstract][Full Text] [Related]
59. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
60. Identification of the key miRNAs associated with survival time in stomach adenocarcinoma.
Liang L; Zhang L; Cui D; Yang D
Oncol Lett; 2017 Oct; 14(4):4563-4572. PubMed ID: 29085454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
